Resilience, positive coping, and quality of life among women newly diagnosed with gynecological cancers

par Manne, Sharon, Myers-Virtue, Shannon, Kashy, Deborah, Ozga, Melissa, Kissane, David, Heckman, Carolyn, Rubin, Stephen C., Rosenblum, Norman
Publié dans Cancer Nurs (2015)

Generation of a Syngeneic Mouse Model to Study the Effects of Vascular Endothelial Growth Factor in Ovarian Carcinoma

par Zhang, Lin, Yang, Nuo, Conejo Garcia, Jose-Ramon, Mohamed, Alisha, Benencia, Fabian, Rubin, Stephen C., Allman, David, Coukos, George
Publié 2002

Intraepithelial T Cells and Tumor Proliferation: Impact on the Benefit from Surgical Cytoreduction in Advanced Serous Ovarian Cancer

par Adams, Sarah F., Levine, Douglas A., Cadungog, Mark G., Hammond, Rachel, Facciabene, Andrea, Olvera, Narciso, Rubin, Stephen C., Boyd, Jeff, Gimotty, Phyllis A., Coukos, George
Publié 2009

A high response rate to liposomal doxorubicin is seen among women with BRCA mutations treated for recurrent epithelial ovarian cancer

par Adams, Sarah F., Marsh, Evelyn B., Elmasri, Wafic, Halberstadt, Steffanie, VanDecker, Stephanie, Sammel, Mary D., Bradbury, Angela R., Daly, Mary, Karlan, Beth, Rubin, Stephen C.
Publié 2011

Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritonea...

par Dizon, Don S., Sill, Michael W., Gould, Natalie, Rubin, Stephen C., Yamada, S. Diane, DeBernardo, Robert L., Mannel, Robert S., Eisenhauer, Eric L., Duska, Linda R., Fracasso, Paula M.
Publié 2011

Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary periton...

par Behbakht, Kian, Sill, Michael W., Darcy, Kathleen M., Rubin, Stephen C., Mannel, Robert S., Waggoner, Steven, Schilder, Russell J., Cai, Kathy Q., Godwin, Andrew K., Alpaugh, R. Katherine
Publié 2011

A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary perito...

par Morgan, Mark A., Sill, Michael W., Fujiwara, Keiichi, Greer, Benjamin, Rubin, Stephen C., DeGeest, Koen, Yamada, S. Diane, Waggoner, Steven, Coleman, Robert L., Walker, Joan L., Mannel, Robert S
Publié 2011

Tissue-based immune monitoring I: Tumor core needle biopsies allow in-depth interrogation of the tumor microenvironment

par Hagemann, Andrea R, Cadungog, Mark, Hagemann, Ian S, Hammond, Rachel, Adams, Sarah F, Chu, Christina S, Rubin, Stephen C, Zhang, Lin, Addya, Kathakali, Birrer, Michael J, Gimotty, Phyllis A, Coukos, George
Publié 2011

BEVACZIUMAB PLUS FOSBRETABULIN IN RECURRENT OVARIAN CANCER: OVERALL SURVIVAL AND EXPLORATORY ANALYSES OF A RANDOMIZED PHASE II NRG ONCOLOGY/GYNECOLOGIC ONCOLOGY GROUP STUDY

par Tewari, Krishnansu S., Sill, Michael W., Coleman, Robert L., Aghajanian, Carol, Mannel, Robert, DiSilvestro, Paul A., Powell, Matthew, Randall, Leslie M., Farley, John, Rubin, Stephen C., Monk, Bradley J.
Publié dans Gynecol Oncol (2020)

Impact of Raloxifene or Tamoxifen Use on Endometrial Cancer Risk: A Population-Based Case-Control Study

par DeMichele, Angela, Troxel, Andrea B., Berlin, Jesse A., Weber, Anita L., Bunin, Greta R., Turzo, Elene, Schinnar, Rita, Burgh, Desiree, Berlin, Michelle, Rubin, Stephen C., Rebbeck, Timothy R., Strom, Brian L.
Publié 2008

Tissue-based immune monitoring II: Multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma

par Hagemann, Andrea R, Hagemann, Ian S, Cadungog, Mark, Hwang, Wei-Ting, Patel, Priya, Lal, Priti, Hammond, Rachel, Gimotty, Phyllis A, Chu, Christina S, Rubin, Stephen C, Birrer, Michael J, Powell, Daniel J, Feldman, Michael D, Coukos, George
Publié 2011

Correlation between Surgeon’s assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cyt...

par Eskander, Ramez N, Kauderer, James, Tewari, Krishnansu S, Mannel, Robert S, Bristow, Robert E, O’Malley, David M, Rubin, Stephen C, Glaser, Gretchen E, Hamilton, Chad A, Fujiwara, Keiichi, Huh, Warner K, Ueland, Frederick, Stephan, Jean-Marie, Burger, Robert A
Publié dans Gynecol Oncol (2018)

Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

par Burger, Robert A., Brady, Mark F., Bookman, Michael A., Monk, Bradley J., Walker, Joan L., Homesley, Howard D., Fowler, Jeffrey, Greer, Benjamin E., Boente, Matthew, Fleming, Gini F., Lim, Peter C., Rubin, Stephen C., Katsumata, Noriyuki, Liang, Sharon X.
Publié 2014

CT perfusion as an early biomarker of treatment efficacy in advanced ovarian cancer: an ACRIN and GOG study

par Ng, Chaan S, Zhang, Zheng, Lee, Susanna I, Marques, Helga S, Burgers, Kyle, Su, Feng, Bauza, Joseph, Mannel, Robert S, Walker, Joan L, Huh, Warner King, Rubin, Stephen C, DiSilvestro, Paul, Martin, Lainie P, Chan, John K, Bookman, Michael A, Coleman, Robert L, Lee, Ting-Yim
Publié dans Clin Cancer Res (2017)

Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0...

par Coleman, Robert L, Brady, Mark F, Herzog, Thomas J, Sabbatini, Paul, Armstrong, Deborah K, Walker, Joan L, Kim, Byoung-Gie, Fujiwara, Keiichi, Tewari, Krishnansu S, O'Malley, David M, Davidson, Susan A, Rubin, Stephen C, DiSilvestro, Paul, Basen-Engquist, Karen, Huang, Helen, Chan, John K, Spirtos, Nick M, Ashfaq, Raheela, Mannel, Robert S
Publié dans Lancet Oncol (2017)

Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

par Walker, Joan L., Brady, Mark F., Wenzel, Lari, Fleming, Gini F., Huang, Helen Q., DiSilvestro, Paul A., Fujiwara, Keiichi, Alberts, David S., Zheng, Wenxin, Tewari, Krishnansu S., Cohn, David E., Powell, Matthew A., Van Le, Linda, Davidson, Susan A., Gray, Heidi J., Rose, Peter G., Aghajanian, Carol, Myers, Tashanna, Alvarez Secord, Angeles, Rubin, Stephen C., Mannel, Robert S.
Publié dans J Clin Oncol (2019)